{"name":"Respirent Pharmaceuticals Co Ltd.","slug":"respirent-pharmaceuticals-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Test","genericName":"Test","slug":"test","indication":"Various conditions","status":"marketed"}]}],"pipeline":[{"name":"Test","genericName":"Test","slug":"test","phase":"marketed","mechanism":"Test is a medication that works by","indications":["Various conditions"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi-gFBVV95cUxPY3JVRTFOODNaWExGN1N2OGFMZHFVTGJSYXpkM28xU01Sb29qVFY2YVJnOFB1TGlGMVdKNkhtY3dyQV8yZHJmZ29MckFNcVZPWUxtSjRoNFB5WmlRM3IwZzZXZm94ZlBCTFBTeEJ4U2dpR3JDbnF1d3NmLXRyZjJuYTlRNkNvZFFUelpfT1J3X25lUmZxYVZrV0I4ZDNUMklYNUd4azlJWEpKNmhiV2VvOEN6c05PUjF5WkFFNWE3aWY0cXBuVFhOQm5Ka3NET0hzdC1ibmxZQUZFTEpOak9FTHhPeURQazVuTC11VnI5NFYzVUdULVg4WTFB?oc=5","date":"2026-02-13","type":"regulatory","source":"scanx.trade","summary":"Aurobindo Pharma's Subsidiary Acrotech Receives FDA Approval for ADQUEY Ointment for Atopic Dermatitis Treatment - scanx.trade","headline":"Aurobindo Pharma's Subsidiary Acrotech Receives FDA Approval for ADQUEY Ointment for Atopic Dermatitis Treatment","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPa0JFM1M2UWo5cmZtRmR6cm9oQkowYUJ2cTZMb3o2c3RxRkRhdWZFemktdTdyeUluVUhwNTIwanZ4UXY3Yzc1dXhEZUs1VFNfYm44YzZaVEZtNlZMYUo1UjY2N3ROMXd4S2lhcWludXJSTHp0TmxOMFZqLVlESV82cXdoQ3VKdHV1OE1pN09HYkRHZ2V3SWhVMEZZSUpoSUk2RV9OU0FheWRZQldhc3Bzb0tlM3o5RzZ1YlBEeFFiZ1lZZmxrNWJtc01tTVlGMV83bGdON1luUQ?oc=5","date":"2026-01-23","type":"pipeline","source":"scanx.trade","summary":"Aurobindo Pharma shares fall 2.02% as stock trades among top losers on Nifty Midcap 150 - scanx.trade","headline":"Aurobindo Pharma shares fall 2.02% as stock trades among top losers on Nifty Midcap 150","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-13","type":"regulatory","source":"CNBC TV18","summary":"USFDA nod for Advair generic positive for Aurobindo Pharma but negative for Cipla; Here's why - CNBC TV18","headline":"USFDA nod for Advair generic positive for Aurobindo Pharma but negative for Cipla; Here's why - CNBC TV18","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-13","type":"regulatory","source":"Moneycontrol.com","summary":"Cipla shares fall up to 2% as Citi says US FDA nod for generic Advair could help Aurobindo Pharma - Moneycontrol.com","headline":"Cipla shares fall up to 2% as Citi says US FDA nod for generic Advair could help Aurobindo Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1gFBVV95cUxQOTFCLXRCMmI5eWo1Vjc5c0tGdWpscEVCNk9LVXh3Yl9BVkc3TDNDUUZWZjJEcGRxN2ZYM1piYUJBTk5STDZ3NDVjejRVNFl2LWpvTVBtUkVveTZvOUpBcDRQaWtzeHliS1UtT3U1ME5YOUgyY2xKcUFyUElxcmxfdHhLNThjRmtvNW95WTd2eko5eEFKcGplZ1dIUjRkMmdkcWpGUzhXOFFjbkdqNndOVzVYcjFKSHdBZjY2b2haTFRBLVFwVF81UEpVdGtRYmNRSGxfWGxR?oc=5","date":"2026-01-12","type":"regulatory","source":"scanx.trade","summary":"USFDA Approval for Advair Generic Creates Mixed Impact for Aurobindo Pharma and Cipla - scanx.trade","headline":"USFDA Approval for Advair Generic Creates Mixed Impact for Aurobindo Pharma and Cipla","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi0wFBVV95cUxOMkxDTlhsS3NiYzc1bzY2SS10QzczYnFMUlQtd3h3QmRyTUI4QThzUGVvTVRpYUZfR3VZbmNwcmFER05kSW5FamJLQy1CTUNoNHp6X0tHck5XUWNCeGQ0dVBUWlRIZmdpbDFQbnF4RG1pdGprbDRIOEUtdGtzZ2w3b0Z0ZDJUNC1nb2lpdTdHdWdyU2RoX2xhRXZRT2dBclM1Y3c2aVM5Qm8xR0FGUUgwcW9QdjFHVUJqQW43bXJoaDlYdVJDQU5KdTlTbkE5b3U4Qmg4?oc=5","date":"2026-01-12","type":"regulatory","source":"scanx.trade","summary":"Respirent and Lannett Secure Final FDA Approval for Generic Advair Asthma Treatment - scanx.trade","headline":"Respirent and Lannett Secure Final FDA Approval for Generic Advair Asthma Treatment","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxQLWpNdTZiZDlXX2x2WUNTNTdPQUQzRlJDVXdLSXFlR2UtemY0UEwzYk0zOTFjLV9YMDhwaVNZdkJudWZhUThQQUhYcS1WSmdZVjZ1UldNdmQzRG5mYTM4S0d1eE1wQXNpcnl4SjZEZzU1Qm12Nm5ydi12THZyQ2lmSTJZMVFyLTNxTjRSUnFibDVsT0tDeG84TGpqNG9sa0p5TW9kTjNFdmtCOTgyaUI0SGV1OXAzSjNLeW4wYmV5Y3o1ZWdXODI5dkR5cw?oc=5","date":"2026-01-12","type":"regulatory","source":"scanx.trade","summary":"Respirent and Lannett Secure FDA Approval for Generic Advair Asthma Treatment - scanx.trade","headline":"Respirent and Lannett Secure FDA Approval for Generic Advair Asthma Treatment","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNeTN0ZlpsMzdFVnp3MEJodjF2WUxaLU85SnhHSlJuN01WM2pIWE51SnBHX2UwUk5ZWVJUVTV1VFdkbGl4YXhQRENFTzA1QzRZV19Ib01yWU9JcDdmLVJGc2JFZVF6NVg2ZmdZU3g4NjVfeDl2Slo1eC1MU3dPOHVtYkgySHI2UEprbVNMOGtqc0xFVzQ5c3VhSTJiWTYzNlJNZHB0WGMxa2R2TGllVWw5YVl3dnhHUVczZHFMVQ?oc=5","date":"2021-06-25","type":"regulatory","source":"Generics and Biosimilars Initiative","summary":"Natco cancer generic approval and advances for Lannett asthma and diabetes products - Generics and Biosimilars Initiative","headline":"Natco cancer generic approval and advances for Lannett asthma and diabetes products","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPTE9XQjd3YUJNeWtLNWdKRFlrN3RVRTlWUTZ5ZlZSN1E0bU5kOUZIWUpSd1FtR3RrTXVpXzNHajlPcEJqdXNqNWxWWUlPN29oUmJtQVFKNlJDSnFTOVpVYU5FZ21pQ0FRV1piYldiRzY4OF81aUZLYkk3Y1ExTGJ3VnRQTG5XUG1fcWlhOVEtb3JRNmh6ZjA2NHVYenVMODlWMmZUUlI3aXp4Z0N4QTk2VzJKdm5xTlVMZHpkUy10bVJEdw?oc=5","date":"2019-10-01","type":"patent","source":"prnewswire.com","summary":"Lannett Enters Into Distribution Agreement For Generic ADVAIR DISKUS® - prnewswire.com","headline":"Lannett Enters Into Distribution Agreement For Generic ADVAIR DISKUS®","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}